{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:07:08Z","timestamp":1794661628068,"version":"4.9.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>This case report is presented to improve our understanding of the atypical immunophenotype of hairy cell leukemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 58-year-old woman presented to our department with fatigue for &gt;10\u200adays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The patient was diagnosed with an increased proportion of abnormal lymphocytes in peripheral blood and bone marrow smear, positive for CD11c, CD19, CD20, CD22, CD25, CD123, CD200, and Kappa, partial expression of CD23, but no expression of CD103, positive for BRAF V600E mutation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions and outcomes:<\/jats:title>\n            <jats:p>Cladribine combined with rituximab achieved complete remission of minor residual disease negativity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Hairy cell leukemia is rare, and the diagnosis and differential diagnosis should be made by combining the patient's medical history, clinical manifestations, immunophenotype, gene detection, and other means. Purine nucleoside analogs are the first-line treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028262","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T14:28:31Z","timestamp":1640269711000},"page":"e28262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["CD103-CD23+ classical hairy cell leukemia"],"prefix":"10.1097","volume":"100","author":[{"given":"Hong-li","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-hua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-fang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-zhang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/ajh.25653","article-title":"Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Maitre","year":"2019","journal-title":"Am J Hematol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12308-009-0037-9","article-title":"Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas","volume":"2","author":"Ott","year":"2009","journal-title":"J Hematop"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood.V53.3.412.412","article-title":"Leukemic reticuloendotheliosis (hairy cell leukemia)","volume":"53","author":"Bouroncle","year":"1979","journal-title":"Blood"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R5-20250504","first-page":"359","article-title":"Diagnosis and differential diagnosis of b-cell chronic lymphoproliferative diseases: Chinese expert consensus, 2018 edition","volume":"39","year":"2018","journal-title":"Chin J Hematol"},{"key":"R6-20250504","first-page":"411","article-title":"Clinical characteristics of 40 cases of hair cell leukemia","volume":"24","author":"Wang","year":"2011","journal-title":"J Clin Hematol"},{"issue":"(Suppl 1)","key":"R7-20250504","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.leukres.2012.11.021","article-title":"Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria","volume":"37","author":"Shao","year":"2013","journal-title":"Leuk Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3324\/haematol.2016.160192","article-title":"Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma","volume":"102","author":"Jallades","year":"2017","journal-title":"Haematologica"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1309\/PMQXVY619Q8Y43AR","article-title":"Immunophenotypic variations in hairy cell leukemia","volume":"125","author":"Chen","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.14129","article-title":"Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial","volume":"174","author":"Chihara","year":"2016","journal-title":"Br J Haematol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.19.02250","article-title":"Randomized phase II study of first-line cladribine with concurrent or delayed rituximab in patients with hairy cell leukemia","volume":"38","author":"Chihara","year":"2020","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1097\/md.0000000000032565","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000}}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:07:30Z","timestamp":1746338850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028262"}},"subtitle":["A case report and review of the literature"],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":14,"journal-issue":{"issue":"51","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028262","relation":{"correction":[{"id-type":"doi","id":"10.1097\/MD.0000000000032565","asserted-by":"object"}]},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"assertion":[{"value":"2021-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}